Given that the structure of the ligand-binding domain is supposed to affect that of the DNA-binding domain35 (even can enhance the binding), and HNF4A is a transcription factor that can affect cirrhosis36, bezafibrate may also be a drug for cirrhosis from this point of view. Here, HNF4A is linked to Cirrhosis.